Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzan D Pas

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medical Microbiology|August 13, 2002
Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapyHubert G M Niesters, Robert A DE Man, Suzan D Pas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisationSuzan D Pas, Robert A de Man, Edwin Fries, et al.
Frontiers in Public Health|November 30, 2019
Zika Virus Outbreak on Curaçao and Bonaire, a Report Based on Laboratory Diagnostics DataStephanie M Lim, Robert Wever, Suzan D Pas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 18, 2005
Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beaconsSuzan D Pas, Suwanna Noppornpanth, Annemiek A van der Eijk, et al.
Journal of Hepatology|December 4, 2016
Hepatitis E virus: Infection beyond the liver?Sven Pischke, Johannes Hartl, Suzan D Pas, et al.
Journal of Clinical Microbiology|February 22, 2008
Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virusSuzan D Pas, Nathalie Tran, Robert A de Man, et al.
Antimicrobial Resistance and Infection Control|May 20, 2026
Re-evaluating microbiological testing and isolation measures for suspected MRSA carriers: insights from a retrospective study in a Dutch tertiary care centerSofie C M Tops, Laura Meddens, Corianne Meijer, et al.
The Journal of General Virology|June 26, 2004
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in catsWillem Huisman, Eefje J A Schrauwen, Suzan D Pas, et al.
Vaccine|April 24, 2008
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in catsWillem Huisman, Eefje J A Schrauwen, Suzan D Pas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 30, 2017
A mutation in the progesterone receptor predisposes to HEV infection in HIV-positive patientsJose D Debes, Suzan D Pas, Zwier M A Groothuismink, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medical Microbiology|August 13, 2002
Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapyHubert G M Niesters, Robert A DE Man, Suzan D Pas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisationSuzan D Pas, Robert A de Man, Edwin Fries, et al.
Frontiers in Public Health|November 30, 2019
Zika Virus Outbreak on Curaçao and Bonaire, a Report Based on Laboratory Diagnostics DataStephanie M Lim, Robert Wever, Suzan D Pas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 18, 2005
Quantification of the newly detected lamivudine resistant YSDD variants of Hepatitis B virus using molecular beaconsSuzan D Pas, Suwanna Noppornpanth, Annemiek A van der Eijk, et al.
Journal of Hepatology|December 4, 2016
Hepatitis E virus: Infection beyond the liver?Sven Pischke, Johannes Hartl, Suzan D Pas, et al.
Journal of Clinical Microbiology|February 22, 2008
Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virusSuzan D Pas, Nathalie Tran, Robert A de Man, et al.
Antimicrobial Resistance and Infection Control|May 20, 2026
Re-evaluating microbiological testing and isolation measures for suspected MRSA carriers: insights from a retrospective study in a Dutch tertiary care centerSofie C M Tops, Laura Meddens, Corianne Meijer, et al.
The Journal of General Virology|June 26, 2004
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in catsWillem Huisman, Eefje J A Schrauwen, Suzan D Pas, et al.
Vaccine|April 24, 2008
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in catsWillem Huisman, Eefje J A Schrauwen, Suzan D Pas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 30, 2017
A mutation in the progesterone receptor predisposes to HEV infection in HIV-positive patientsJose D Debes, Suzan D Pas, Zwier M A Groothuismink, et al.
Pageof 10